Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
Condition: Bone Cancer Intervention: Drug: regorafenib tablet Sponsors: Gustave Roussy, Cancer Campus, Grand Paris; Princess Maxima Center for Pediatric Oncology; Bayer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer | Cancer & Oncology | Chemotherapy | Ewing's Sarcoma | Pediatrics | Research | Sarcomas